Unit KM Biologics Applied For Marketing Authorization Of Kd-370, Combination Vaccine For Pertussis, Diphtheria, Tetanus, Inactivated Polio And Hib

Meiji Holdings

25/04/2022 07:15

April 25 (Reuters) - Meiji Holdings Co Ltd  2269.T :
    * UNIT KM BIOLOGICS APPLIED FOR MARKETING AUTHORIZATION OF
KD-370,
COMBINATION VACCINE FOR PERTUSSIS, DIPHTHERIA, TETANUS,
INACTIVATED POLIO AND HIB

Source text for Eikon:  ID:nTSpy80937 
Further company coverage:  2269.T